Terms and Conditions.

Plain-language summary

This summary highlights the main points. The numbered Terms below form the legally binding agreement.

• IAMRegen and I AM Regen are programme names used by MSK REGEN, a charitable incorporated organisation registered in England and Wales under charity number 1211400.
• IAMRegen membership is professional programme membership. It does not make a person a legal member or trustee of MSK REGEN and gives no voting, ownership or governance rights.
• Membership normally renews annually where the member has expressly selected automatic renewal. Renewal reminders and straightforward online cancellation will be provided.
• Admission, Fellowship, awards, authorship, publication, teaching rights, certification and Centre of Excellence status are never guaranteed merely because a fee has been paid.
• Members may be eligible to participate in consensus work. Authorship or contributor recognition depends on documented contribution and the applicable publication criteria.
• Case MDT is a confidential multidisciplinary professional discussion for appropriately qualified healthcare professionals. It may provide a non-binding collective opinion and written discussion summary. The submitting clinician remains solely and continuously responsible for the patient and may accept, reject or depart from the opinion. Patient-identifiable information is prohibited under the standard service.
• Every IAMRegen executive, board, committee, faculty, advisory and honorary position is a revocable Programme Appointment controlled by MSK Regen. It confers no charity trusteeship, employment, voting right or authority to bind MSK Regen.
• IAMRegen owns or controls its brand, platform, programme materials, compiled outputs and databases. Members receive only the limited rights expressly granted in these Terms.
• Users remain responsible for their professional practice, patient care, regulatory compliance, content and conduct.
• IAMRegen may moderate content and suspend access where this is reasonably necessary to protect users, patients, the charity, the scientific record, the service or the public.
• Mandatory rights under applicable consumer, data-protection and other local laws are preserved.

1. Who we are and who contracts with you

1.1 These Terms and Conditions (the Terms) are issued by MSK REGEN, a charitable incorporated organisation registered in England and Wales under charity number 1211400, whose registered contact address is MSK House, London Road, Silk Willoughby, Sleaford, Lincolnshire NG34 8NY, United Kingdom (MSK Regen, we, us or our).

1.2 IAMRegen, I AM Regen and the International Association of Musculoskeletal Regeneration are programme names and trading styles used by MSK Regen. They are not separate incorporated bodies. Any contract created under these Terms is between you and MSK Regen.

1.3 MSK Regen operates IAMRegen to advance education, research, responsible professional collaboration and public benefit in musculoskeletal regeneration. All income and assets of MSK Regen must be applied in accordance with its charitable purposes and governing document.

1.4 Our contact details are:

• Email: [email protected]
• Telephone: 0330 001 0048
• Public website: https://iamregen.com
• Member portal: https://app.iamregen.com

1.5 If the registered or correspondence address changes, the current address shown on the Charity Commission register and our website will apply from the date it is published. A change of address does not change the identity of the contracting body.

2. Scope, hierarchy and definitions

2.1 These Terms govern access to and use of our websites, member portal, membership programme, annual Congress, events, masterclasses, journal and publishing activities, consensus and Delphi programmes, fellowships, awards, directories, Centres of Excellence, Case MDT, training, digital resources, communications and related services (together, the Services).

2.2 Additional rules may apply to a particular Service, including event booking terms, author instructions, research participant information, competition rules, scholarship terms, Centre of Excellence criteria, brand guidelines, codes of conduct and the Case MDT Rules. We will make any applicable additional rules available before they bind you.

2.3 If documents conflict, the following order applies, unless mandatory law requires otherwise:

• a separately signed written agreement between you and MSK Regen;
• specific terms presented for the particular Service or transaction;
• the Case MDT Rules, author instructions or research participant information, for the subject they regulate;
• these Terms;
• the Privacy Notice and Cookie Notice, which govern personal-data and tracking matters rather than commercial rights.

2.4 In these Terms:

• Account means the personal portal account allocated to or created by a user.
• Association Content means content, materials, data compilations and intellectual property owned by or licensed to MSK Regen or made available through IAMRegen, excluding User Content.
• Authorised Delegate means a person or body given written authority by the charity trustees of MSK Regen to exercise specified programme functions, subject to the limits, reporting duties and revocation rights in that authority.
• Business User means a person acting wholly or mainly for purposes connected with a trade, profession, business, craft, institution or employer.
• Case MDT means the confidential multidisciplinary professional-discussion service described in section 19 and the separate Case MDT Rules.
• Consumer means a natural person acting wholly or mainly outside their trade, business, craft or profession.
• Congress means an IAMRegen annual scientific meeting and associated sessions, ceremonies and activities.
• Content means text, data, images, audio, video, software, presentations, submissions, communications, profiles, recordings and other material.
• Delphi Process means a structured, multi-round method used to seek consensus.
• Fees means fees and charges payable for a Service.
• Member means a person holding a current contractual membership of the IAMRegen professional programme.
• Programme Appointment means any IAMRegen executive, presidential, board, committee, scientific, advisory, faculty, reviewer, ambassador, assessor, speaker, Fellow, honorary or similar programme position, function, status or title.
• Case MDT Opinion means a non-binding collective professional opinion or observation arising from a Case MDT discussion, based only on the information made available for that discussion.
• Case MDT Discussion Summary means the written record issued by IAMRegen recording material matters, evidence, uncertainties, observations and differing views raised during a Case MDT.
• Platform means iamregen.com, app.iamregen.com and any successor website, application or digital environment operated for IAMRegen.
• Submission means an abstract, manuscript, poster, presentation, consensus response, dataset, case report, educational item or other material submitted for assessment, publication, presentation or formal programme use.
• User Content means Content submitted, uploaded, posted or otherwise supplied by or on behalf of a user.

2.5 References to law include that law as amended, replaced or re-enacted. Including and similar words do not limit the words preceding them.

3. Acceptance, capacity and electronic contracting

3.1 You accept these Terms when you tick an acceptance box, create or use an Account after being shown the Terms, pay a Fee, redeem an invitation, submit Content, register for a Service or otherwise expressly agree to them.

3.2 You must be at least 18 years old and legally capable of entering a contract. If you act for an organisation, you confirm that you have authority to bind it. An organisation remains responsible for the acts and omissions of each person using a Service on its behalf.

3.3 Account creation alone does not guarantee admission to membership or access to a paid or restricted Service.

3.4 We record the version accepted, the Account, date, time and relevant transaction. We will make the accepted version available in a durable form, such as by email, downloadable file or versioned portal record.

3.5 Marketing consent, public-profile consent, consent to optional cookies and any consent needed for a distinct use of personal data are separate from acceptance of these Terms. Refusing optional consent will not prevent access to core Services unless the information is genuinely required to deliver the requested Service.

4. Nature and availability of the Services

4.1 IAMRegen is an international professional, scientific and educational programme. Services may include membership, Congress, scientific meetings, consensus projects, publishing, professional directories, masterclasses, fellowships, awards, educational resources, Case MDT and recognition programmes.

4.2 Published descriptions, eligibility criteria and core paid benefits form part of the relevant contract. We may develop, replace or discontinue non-material features and may make changes needed for law, safety, security, scientific integrity, accessibility, technology or the charity's proper administration.

4.3 We will not materially reduce a core paid Service during a paid period without a valid reason. Where a material reduction substantially deprives a Consumer of what was purchased, we will offer an appropriate substitute, extension, proportionate refund or cancellation right as required by law.

4.4 Unless expressly stated, we do not guarantee:

• uninterrupted or error-free availability;
• acceptance into membership, Fellowship, a programme, award or event;
• publication, authorship, citation, academic credit or indexing;
• a grant, fellowship placement, referral, patient lead or commercial opportunity;
• any particular speaker, faculty member, programme item or collaborator;
• regulatory approval, reimbursement or availability of any treatment, device, product or technique;
• professional advancement, clinical outcome, financial return or reputational benefit.

4.5 Sponsored content, exhibitors and commercial support will be identified where appropriate. Sponsorship does not by itself constitute scientific or clinical endorsement.

4.6 Sponsorships, exhibitions, institutional packages, commissioned projects and other business arrangements may require a separate written agreement.

5. IAMRegen legal status, governance and Programme Appointments

5.1 IAMRegen is a programme and working name operated solely by MSK Regen. It has no legal personality, assets, constitutional membership or governing body separate from MSK Regen. Ultimate governance, fiduciary responsibility and control rest exclusively with the charity trustees of MSK Regen acting collectively under its governing document, charitable purposes and applicable law.

5.2 IAMRegen membership is contractual membership of a professional programme only. It does not make a person:

• a constitutional or corporate member of MSK Regen under its governing document or the Charities Act 2011;
• a charity trustee, officer, director, employee, worker, partner, agent or representative of MSK Regen;
• entitled to vote on, direct or participate in the governance of MSK Regen;
• entitled to any ownership, equity, distribution, profit, asset or proprietary interest in MSK Regen; or
• authorised to bind MSK Regen, incur liability in its name or speak on its behalf.

5.3 Programme consultation, member polls, scientific votes, Delphi rounds, elections, surveys, committees, councils, boards and advisory roles are consultative or scientific only. They do not bind the charity trustees and confer no constitutional vote or governance power.

5.4 Every IAMRegen president, president-elect, vice-president, executive, board or committee member, Scientific Advisory Board member, Fellow, honorary officer, faculty member, reviewer, ambassador, assessor, speaker and holder of a similar function, status or title holds a Programme Appointment. A Programme Appointment is not an office of MSK Regen, charity trusteeship or constitutional membership.

5.5 Executive and presidential Programme Appointments may be made only by the charity trustees. Other Programme Appointments may be made by the trustees or by an Authorised Delegate acting within written delegated authority. Members have no right to nominate, elect, approve or veto a Programme Appointment unless the trustees expressly invite a non-binding consultation.

5.6 Programme Appointments are personal, honorary and unpaid, except for reimbursement of reasonable expenses authorised in advance. Any separately paid services require a distinct written agreement approved under MSK Regen's financial and conflicts procedures. Payment for separate services does not create a right to the honorary title or make the title itself remunerated.

5.7 Subject to section 5.10, the trustees or an Authorised Delegate acting within their authority have the exclusive power to create, fill, define, alter, suspend, restrict, reassign, remove, replace or decline to renew a Programme Appointment. They may impose an immediate interim suspension without advance notice where they reasonably consider this necessary to protect a patient or person, data, safeguarding, scientific integrity, the charity, its reputation, property, legal compliance or effective administration.

5.8 A Programme Appointment may be ended at any time for a lawful reason which the decision-maker, acting lawfully, in good faith and consistently with the charity's interests, considers sufficient. There is no entitlement to renewal, compensation, continued public listing, continued access, continued use of a title or continued use of IAMRegen marks. Any review under section 27 does not confer a right to remain in post or delay an interim protective measure.

5.9 A Programme Appointment creates no minimum work obligation, promise of work, obligation to accept tasks, employment or worker status, partnership, agency, fiduciary relationship, governance right or authority to bind MSK Regen. Each appointee must comply with their appointment instrument, confidentiality, intellectual-property, conflicts, data-protection, safeguarding, conduct and brand requirements.

5.10 This section does not govern the appointment or removal of a charity trustee, which is controlled exclusively by MSK Regen's governing document and charity law. Ending a Programme Appointment does not automatically end a separately paid membership or contract; those rights are governed by the applicable contract and section 26. Conversely, membership creates no right to any Programme Appointment.

5.11 Membership Fees are consideration for programme Services and are not charitable donations unless expressly identified as donations. No Gift Aid entitlement arises from a membership or event Fee merely because MSK Regen is a charity.

6. Eligibility, applications and credentials

6.1 Eligibility depends on the membership category or Service. We may require evidence of identity, age, qualifications, employment, institutional affiliation, professional registration, university enrolment, insurance, good standing or other relevant credentials.

6.2 You must provide complete, accurate, current and non-misleading information. You must promptly update material changes, including any restriction, suspension or expiry of a professional registration relevant to eligibility.

6.3 We may verify information against issuing institutions, professional registers and reliable public sources, or request further evidence. We will process verification information in accordance with the Privacy Notice.

6.4 Applications are assessed against published criteria, available capacity, programme balance, safety, scientific integrity, charitable purpose and other legitimate programme considerations. Admission remains at our discretion, exercised lawfully and in good faith. We may accept, decline, defer, place conditions on or request amendments to an application.

6.5 Unless required by law, we are not obliged to disclose confidential assessment material, references, scoring, legal advice, security information or information about another applicant. We may provide a brief outcome or review route where appropriate.

6.6 Paying a Fee before all admission conditions are satisfied does not override those conditions. If we decline an application after taking payment, we will refund the relevant Fee unless the payment related to a separate Service already supplied or the application involved fraud or chargeback costs lawfully recoverable from a Business User.

6.7 Credentials remain the responsibility of the user. IAMRegen verification is not a regulatory guarantee, employment reference, credentialing service or representation of clinical competence.

7. Accounts and security

7.1 Accounts are personal and non-transferable. You must not share credentials, permit another person to impersonate you, create duplicate Accounts without permission or use another person's Account.

7.2 You are responsible for maintaining appropriate password and device security and for activity conducted through your Account, except to the extent caused by our breach of duty.

7.3 You must notify [email protected] immediately if you suspect unauthorised access, loss of credentials, data exposure or misuse.

7.4 We may require multi-factor authentication, password resets, identity checks or other proportionate security measures. We may temporarily restrict an Account while investigating a credible security concern.

7.5 You must not circumvent access controls, probe vulnerabilities, introduce malicious code, automate unauthorised access or interfere with the security or operation of the Platform.

8. Membership categories, status and benefits

8.1 Categories may include Member, Student Member, Fellow, Honorary Member or Fellow, Founder, Founder-sponsored Member, Speaker and other categories published by us.

8.2 Membership begins when we confirm admission and payment or an authorised waiver. Unless the offer states otherwise, an accepted and paid applicant is a Member for the contractual membership period. Some distinctions, privileges and recognition remain conditional on additional criteria.

8.3 Fellowship, Honorary status, Founder status, teaching rights, committee roles, awards and similar distinctions are honours or Programme Appointments, not products that can be purchased. The distinction itself is not sold. Any different Fee must relate transparently to membership Services or benefits rather than purchase of the distinction. Programme Appointments are controlled under section 5 and may be granted, reviewed, restricted, suspended, withdrawn or not renewed accordingly.

8.4 Membership benefits are those described at the point of purchase. Benefits may be subject to registration, capacity, professional eligibility, deadlines, location, contribution, attendance, availability and additional rules.

8.5 Congress entry included with a membership requires timely registration and remains subject to capacity, safety and event rules. Failure to register or attend does not ordinarily terminate membership and does not create a refund entitlement, but the person will not receive attendance-dependent benefits.

8.6 Consensus participation, publication recognition, certificates, designations, fellowships, awards and Centre of Excellence status are governed by their own criteria. Membership creates eligibility to be considered or participate; it does not guarantee the outcome.

8.7 Membership is not transferable and cannot be sold, assigned or shared. Institutional payment of an individual's Fee does not transfer the individual's membership to the institution.

8.8 Complimentary, sponsored or waived membership has the same conduct obligations as paid membership. Any future paid renewal requires clear advance information and, where required, express authorisation.

9. Fees, taxes and payment

9.1 Fees, currency, billing interval and material inclusions are displayed before payment. Unless stated otherwise, prices include taxes that we are legally required to include. Any tax, bank, card or currency-conversion charge imposed by a user's provider remains the user's responsibility.

9.2 Payments may be processed by Stripe or another disclosed payment provider. The provider receives and processes card details under its own privacy information. We do not ordinarily store full card numbers.

9.3 You confirm that you are authorised to use the selected payment method and that billing information is accurate.

9.4 If payment fails, is reversed or is reasonably suspected to be fraudulent, we may pause the relevant Service while giving a reasonable opportunity to correct the issue. A Business User remains liable for undisputed Fees and reasonable recovery costs caused by its breach, subject to law.

9.5 We may correct an obvious pricing or description error before performance. If you do not accept the corrected price, we will cancel and refund the affected purchase.

9.6 Fee waivers, scholarships, sponsorships and promotional arrangements apply only to the specified person, period and Service and have no cash value.

10. Annual renewal and cancellation of membership

10.1 Where you expressly select automatic renewal, membership renews for successive annual periods using the payment method on file until cancelled. The checkout must clearly identify the renewal price or how it will be calculated, the billing interval and how to cancel.

10.2 We will send a renewal reminder within a reasonable period before the renewal date. Our operating standard is an initial reminder at least 30 days before annual renewal and a further reminder approximately 7 days before renewal, where contact details remain valid.

10.3 We will give at least 30 days' notice of an increase to the recurring Fee. You may cancel before renewal if you do not accept the new Fee.

10.4 You may switch off automatic renewal at any time through the portal or by contacting [email protected]. Cancellation stops future renewal and normally leaves existing benefits active until the end of the paid period.

10.5 Cancelling automatic renewal does not ordinarily create a refund of the current period. Statutory cancellation rights and remedies remain unaffected.

10.6 For additional protection and to accommodate evolving international subscription rules, a Consumer may cancel an annual renewal within 14 days after renewal. We may deduct a proportionate amount for Services supplied during that renewal period where permitted by law and where the Consumer requested immediate continued performance.

10.7 A complimentary or sponsored period will not convert into a paid recurring membership unless the person has been clearly informed of the amount and date and has expressly authorised the paid renewal as required by law.

11. Consumer cancellation, refunds and credits

11.1 If you are a Consumer buying membership or another service online, you may have a statutory right to cancel within 14 days after the contract is made. We will provide the required cancellation information and the model form at Part E. You do not have to use the form; a clear cancellation statement is sufficient.

11.2 If you ask us to begin a service during a statutory cancellation period, you expressly request early performance. If you then cancel before the service is fully performed, we may deduct a lawful and proportionate amount for what has been supplied. We will obtain any separate express consent and acknowledgement required before supplying digital content that would cause a cancellation right to be lost.

11.3 A booking for Congress, a masterclass, dinner, ceremony or another leisure or educational event to be supplied on a specified date may be excluded from the statutory change-of-mind cancellation right. The absence of a cooling-off right does not affect rights arising from cancellation by us, material misdescription, non-performance or other mandatory law.

11.4 Except for statutory rights, a published goodwill policy or event-specific terms, Fees are not refundable merely because a person changes their mind, cannot attend, fails to satisfy attendance-dependent criteria or does not use a Service.

11.5 If we cancel a paid event and do not provide a materially equivalent rescheduled event accepted by you, we will refund the Fee paid for the cancelled event. A Consumer will not be required to accept a voucher or credit instead of a cash refund where the law gives a refund right.

11.6 If we make a material change that substantially alters the nature, date or location of a separately paid event, affected purchasers may accept the change, transfer where permitted or request the remedy required by applicable law. Speaker, timetable, room and non-material programme changes do not normally constitute material changes.

11.7 Unless required by law or caused by our breach, we are not responsible for travel, accommodation, visa, insurance, currency or other incidental costs. Attendees should use flexible arrangements and appropriate insurance.

11.8 Refunds are returned to the original payment method where practicable and within the legally required period. We may conduct reasonable anti-fraud and identity checks.

12. Events, Congress and attendance

12.1 Event details, location, date, format, capacity, eligibility and price are published separately. Registration is complete only when confirmed by us.

12.2 We may make reasonable changes to speakers, faculty, session order, rooms, content or delivery method. We will notify registered attendees of material changes where practicable.

12.3 We may refuse entry or remove a person where reasonably necessary for safety, security, professional conduct, legal compliance, capacity, non-payment, credential concerns or protection of others. A person removed for serious breach is not entitled to a refund except where mandatory law requires one.

12.4 Attendees must comply with venue rules, safety instructions, professional standards and the event code of conduct. Harassment, discrimination, intimidation, disruptive conduct, unauthorised commercial solicitation and unsafe behaviour are prohibited.

12.5 Tickets, badges and registrations are personal and may be transferred only with our prior written approval. We may refuse a transfer where eligibility, sanctions, security or capacity requirements are not satisfied.

12.6 Attendees are responsible for passports, visas, travel requirements, insurance, health requirements and permissions needed to attend. A visa refusal does not automatically create a refund right unless event-specific terms say otherwise.

12.7 Personal property remains at the attendee's risk except to the extent loss is caused by our negligence or another liability that cannot lawfully be excluded.

12.8 Events may be photographed, recorded or streamed. General audience and atmosphere recording may be carried out for legitimate educational, archival and promotional purposes where lawful and with appropriate notice. We will seek separate permission where required for a featured interview, testimonial or close-up promotional use. Attendees may request a practical no-feature identifier or notify the event team, although incidental background appearance cannot always be avoided.

12.9 Attendees must not record, stream, photograph or distribute protected sessions, patients, confidential material or other attendees without all required permissions.

12.10 If an event cannot proceed because of circumstances beyond reasonable control, we will act fairly and in accordance with applicable law. We may reschedule, move online or provide a substitute where materially equivalent. If the contracted event is not supplied, refund rights under section 11 apply.

13. Masterclasses, professional education and third-party products

13.1 Training and masterclasses are educational activities for people who satisfy the stated eligibility requirements. They do not replace regulated education, supervised practice, local credentialing, manufacturer training or independent professional judgement.

13.2 A certificate of attendance or completion confirms only the activity expressly stated. It does not certify clinical competence, create specialist registration or authorise practice.

13.3 A person may use IAMRegen Trained or another permitted completion description only in the exact form, context and period specified by our brand rules. The person must not use certified, accredited, approved, endorsed or similar language unless IAMRegen has expressly awarded that designation under a formally assessed programme.

13.4 Medical devices, pharmaceuticals, biologics and other products may be demonstrated or discussed. Regulatory status, indications, instructions and availability vary between jurisdictions. Users remain responsible for verifying local requirements, maintaining competence, obtaining consent and practising within professional scope.

13.5 A supplier's presence, sponsorship or product demonstration does not amount to IAMRegen warranty or endorsement. Where IAMRegen expressly makes an endorsement, its scope will be stated in writing.

14. Designations, awards, fellowships and Centres of Excellence

14.1 IAMRegen may operate Fellow, award, fellowship, trained-person, certified-person, recognised-centre and Centre of Excellence programmes. Each is subject to published criteria, evidence requirements, assessment, conflicts controls, duration, renewal and monitoring.

14.2 Designations are programme marks owned or controlled by MSK Regen. They are not government, university, regulator or professional-body accreditation unless expressly stated.

14.3 We may audit compliance, request updated evidence, impose corrective conditions, suspend or withdraw a designation where criteria are no longer met, information was inaccurate, Fees are unpaid, brand rules are breached or continued use creates a credible safety, legal or reputational risk.

14.4 Except in urgent interim cases, the holder will ordinarily receive notice of the concern and a reasonable opportunity to respond. An appeal may be made under section 27.

14.5 The holder must immediately stop using the relevant name, mark, badge, certificate and representation when entitlement ends or is suspended.

14.6 Selection decisions involve expert judgement and may reflect capacity, programme balance and charitable priorities. We do not guarantee selection, funding, travel permission, placement, publication or any employment or commercial outcome.

15. Professional conduct, conflicts and member obligations

15.1 Users must act lawfully, honestly, professionally and respectfully and must protect patient welfare, scientific integrity, confidentiality and the reputation of the programme.

15.2 You must:

• maintain any registration, insurance, competence and permissions required for your activities;
• accurately describe your qualifications, membership and designations;
• disclose relevant conflicts of interest in scientific, educational, assessment and publishing activities;
• comply with anti-bribery, anti-fraud, competition, sanctions and export-control laws;
• protect non-public programme material, case information and personal data;
• follow research ethics, publication ethics and applicable institutional approvals;
• notify us of a material circumstance that makes you ineligible or creates a serious safety or integrity concern; and
• cooperate reasonably with a lawful investigation into misuse of the Services.

15.3 You must not:

• harass, discriminate against, threaten, defame or intimidate another person;
• misrepresent IAMRegen membership as clinical endorsement, competence certification or authority to act for us;
• use the directory or member details for bulk marketing, recruitment, scraping or unsolicited sales;
• offer, solicit or accept an improper benefit connected with a decision or programme;
• manipulate a vote, peer review, consensus round, award, abstract assessment or authorship decision;
• upload unlawful, infringing, deceptive, unsafe, malicious or confidential material without authority;
• use a Service to provide unregulated treatment or direct patient care in IAMRegen's name; or
• bring IAMRegen, MSK Regen or another member into disrepute through dishonest or materially misleading use of the programme or its marks.

15.4 Legitimate scientific disagreement and good-faith criticism do not by themselves breach these Terms. Users must distinguish evidence, opinion, hypothesis and promotion appropriately.

16. Online safety, illegal content and moderation

16.1 The Platform is intended for adults and professional or academic use. Users may encounter Content supplied by others. We do not endorse User Content merely because it appears on the Platform.

16.2 Illegal Content and activity are prohibited, including fraud, threats, terrorism, hate offences, unlawful harassment, child sexual exploitation or abuse material, non-consensual intimate imagery, cyberflashing, encouragement or assistance of suicide or serious self-harm, intellectual-property infringement, malicious software and unlawful disclosure of personal or confidential data.

16.3 We use proportionate systems and processes to address safety and integrity risks. These may include access controls, user reports, human review and automated technical tools for security, spam, malware, duplicate material or other disclosed functions. We do not use automated tools as the sole judge of scientific merit or professional competence unless this is clearly disclosed and a meaningful human review is available.

16.4 Anyone may report suspected illegal or prohibited Content to [email protected], identifying the Content, its location, the reason and their contact details. We may request information reasonably needed to assess the report.

16.5 We may restrict visibility, remove Content, preserve evidence, issue warnings, limit functions, suspend Accounts or report matters to competent authorities where reasonably necessary. We may act without advance notice where notice would prejudice safety, an investigation, legal compliance or evidence preservation.

16.6 Where appropriate and lawful, we will give the affected user a clear reason for a moderation decision and the relevant contractual or legal basis. The user may request review within 30 days. Reviews will be handled by a person not solely responsible for the original decision where reasonably practicable.

16.7 We may report detected and previously unreported child sexual exploitation or abuse material, and other material requiring mandatory reporting, to the National Crime Agency or another competent body and preserve required information.

16.8 Users must not make knowingly false, abusive or bad-faith reports. Repeated serious misuse of reporting or complaint processes may result in restriction.

16.9 These Terms do not create a general obligation to pre-screen every item. Nothing limits a statutory online-safety, hosting or reporting duty that applies to us.

17. Consensus, Delphi processes and scientific integrity

17.1 IAMRegen may invite eligible users to participate in a Delphi Process, consensus statement, guideline or other scientific project. The applicable protocol, methodology, contribution thresholds, conflicts process and publication plan will be provided separately.

17.2 Membership or payment creates no guaranteed authorship, byline, vote, outcome or right to have a view adopted. Recognition depends on actual, documented contribution and the criteria applicable to the output.

17.3 Participants must provide considered responses, disclose relevant interests, preserve embargoes and confidentiality, avoid collusion and complete required declarations and rounds within deadlines.

17.4 We may validate, clean, analyse, aggregate, interpret and report response data according to the published methodology. We may exclude duplicate, fraudulent, ineligible, substantially incomplete or protocol-violating responses, documenting material exclusions where scientific standards require.

17.5 Authorship will follow the journal's policy and recognised publication standards, normally including the current ICMJE authorship criteria where appropriate. People who do not meet authorship criteria may be identified as collaborators, Delphi participants, group members or acknowledged contributors.

17.6 Each named author must have the opportunity to review the relevant manuscript, approve the final version, accept accountability and complete required conflict disclosures. Attendance alone, payment alone or completion of a survey alone does not guarantee authorship.

17.7 Participants retain ownership of their pre-existing material. They grant MSK Regen a worldwide, perpetual, irrevocable, royalty-free, transferable and sublicensable licence to use, analyse, reproduce, adapt, translate, combine, publish, archive and distribute their responses and contributions for the relevant project, scientific record, education and related non-commercial or charitable purposes, subject to data-protection law and the applicable protocol.

17.8 MSK Regen owns the compilation, selection, arrangement, analysis, editorial text, programme database and Association-created output, without taking ownership of a participant's pre-existing intellectual property.

17.9 Consensus outputs express the result of the stated process. They may not represent every participant's personal view and do not replace professional judgement, regulation or patient-specific care.

17.10 Where an activity constitutes research involving human participants, separate ethics, sponsorship, participant information and consent arrangements apply. These Terms are not a substitute for research consent.

18. Journal, abstracts, posters and publication

18.1 IAMRegen may operate or support a journal, proceedings, book series, repository or other publishing programme. Editorial and peer-review decisions remain independent of membership sales and sponsorship.

18.2 A submitter confirms that:

• the Submission is original or all necessary permissions have been obtained;
• all named authors have approved submission and satisfy the stated authorship policy;
• no deserving author has been omitted and no inappropriate author included;
• all patient consents, ethics approvals, registrations, licences and institutional permissions have been obtained;
• the Submission is accurate to the best of the authors' knowledge and does not fabricate, falsify, plagiarise or unlawfully reuse material;
• conflicts, funding, prior publication, preprints and material use of artificial intelligence have been disclosed as required; and
• the Submission does not infringe intellectual property, confidentiality, privacy or other rights.

18.3 Authors retain copyright in a Submission unless a separate agreement says otherwise. On submission, the rights holder grants MSK Regen a worldwide, royalty-free, non-exclusive licence to assess, copy, format, screen, peer review, archive and communicate the Submission for editorial purposes.

18.4 On acceptance, the rights holder grants the publication licence stated in the author instructions. It may include a perpetual, irrevocable licence to publish, reproduce, translate, adapt for accessibility, distribute, archive, index, text- and data-mine, make machine-readable, promote and make the work available under a specified Creative Commons or other open-access licence.

18.5 To the extent permitted by law, authors consent to reasonable editing, formatting, translation, correction, accessibility adaptation and publication with their names, affiliations, biographies and disclosures. We will not knowingly make a change that materially misrepresents an author's conclusions without appropriate editorial process.

18.6 Editorial bodies may reject, correct, withdraw, retract, annotate, preserve or investigate material in accordance with publication ethics, law and the integrity of the scholarly record. Publication and archival licences survive withdrawal where reasonably necessary to preserve that record.

18.7 Submission or publication Fees, if any, do not buy acceptance, favourable review, authorship or editorial influence.

18.8 A submitter providing another person's details must be authorised to do so and must provide or enable us to provide the applicable privacy information. MSK Regen remains responsible for its own data-protection duties.

19. Case MDT and clinical case discussion

19.1 Case MDT is a confidential multidisciplinary professional discussion service restricted to appropriately qualified healthcare professionals acting wholly or mainly for purposes connected with their professional practice. It enables clinicians from relevant disciplines to discuss an effectively anonymised case prospectively or retrospectively, consider evidence and uncertainty, identify material risks and express professional observations or a non-binding collective opinion.

19.2 Case MDT is not an emergency service, patient referral, assumption of care, prescription, treatment authorisation, guarantee of outcome or substitute for examination and patient care. Unless a separate signed agreement expressly establishes a different regulated service, it is not a formal clinical second-opinion service.

19.3 The submitting clinician remains the treating or responsible professional and retains sole and continuing responsibility for the patient, including assessment, investigations, diagnosis, consent, treatment, documentation, referral, follow-up, local governance and compliance with professional and legal requirements. The submitting clinician may accept, reject or depart from a Case MDT Opinion and must independently assess its relevance, verify material information and not rely on it as the sole basis for a clinical decision.

19.4 Before every case is submitted or discussed, the submitting clinician must complete the case-specific Professional Acknowledgement in Part D. Acceptance must be recorded against the applicable version, user identity, professional registration, case reference, date and time. General membership acceptance does not replace this case-specific acknowledgement.

19.5 Under the standard Case MDT service, patient-identifiable and pseudonymised personal data are prohibited. Only case information that has been effectively anonymised so that the patient is not reasonably identifiable may be submitted. Detailed requirements appear in the Case MDT Rules at Part D.

19.6 Direct identifiers, hidden metadata, full dates of birth, full postcodes, record numbers, facial images, distinctive tattoos and unusually specific combinations of facts must be removed or generalised. DICOM and image metadata must be checked before upload.

19.7 If a case cannot be safely anonymised, it must not be submitted under the standard Service. Any exceptional identifiable-data pathway requires prior written approval, a separate data agreement, a documented lawful basis and Article 9 condition, security assessment and any required patient consent, institutional authority or ethics approval.

19.8 We may reject, quarantine or delete material that appears identifiable, unsafe, outside scope, incomplete, unlawful or inappropriate. We may notify the submitter of a suspected data incident and take protective action.

19.9 Panel comments, a Case MDT Opinion and a Case MDT Discussion Summary are based solely on the limited information selected and provided by the submitting clinician. IAMRegen and the panel do not examine the patient, verify the complete clinical record or warrant that the information supplied is complete, accurate or current. Opinions may differ and scientific or regulatory uncertainty may remain.

19.10 Where included, IAMRegen may issue a written Case MDT Discussion Summary recording material matters, evidence, questions, uncertainties, professional observations and differing views raised. It may include a non-binding collective professional opinion. It must not be represented as an IAMRegen treatment authorisation, regulatory approval, guarantee or transfer of clinical responsibility.

19.11 The Science Board or another appointed reviewer may confirm that the Discussion Summary follows the IAMRegen process and faithfully records the material discussion. That process review is not a guarantee of clinical accuracy, approval of patient-specific treatment or assumption of patient care by the reviewer, the Science Board, IAMRegen or MSK Regen.

19.12 Participants must maintain confidentiality, declare conflicts and must not contact a patient, assume care, solicit work or use case information outside the permitted discussion.

19.13 The submitter grants MSK Regen the rights needed to host, discuss, analyse and prepare the Case MDT Discussion Summary. We may use genuinely anonymised and aggregated learning points internally for education, service evaluation, safety and quality improvement. External publication, research or promotional use of a recognisable case requires a separate assessment and any necessary consent, ethics approval and licence.

19.14 Subject to sections 30 and 31 and to the fullest extent permitted by law, MSK Regen, IAMRegen, the Science Board and panel members do not accept responsibility for the submitting clinician's independent decision to adopt, reject or modify a Case MDT Opinion, or for treatment or patient outcomes arising from that decision. Nothing excludes responsibility that cannot lawfully be excluded, and each regulated professional remains responsible to their regulator for their own conduct and advice.

19.15 Case MDT is subject to Part D, which forms part of these Terms.

20. Medical, scientific and regulatory disclaimer

20.1 Association Content, events, publications, consensus outputs, directories, patient information and masterclasses are provided for general education, scientific exchange and professional development. Case MDT has the specific non-binding professional-discussion status described in section 19 and Part D.

20.2 Nothing creates a clinician-patient relationship between a patient and MSK Regen, IAMRegen, a trustee, staff member, faculty member, author, panel member or Member.

20.3 Healthcare professionals must use independent professional judgement, work within competence, obtain informed consent, comply with local regulation and verify evidence, indications, product status and manufacturer information.

20.4 Patients and members of the public must seek advice from an appropriately qualified healthcare professional. They must not start, stop or delay care solely because of Association Content.

20.5 Scientific knowledge and regulation evolve. Content may become outdated and views may differ. We do not guarantee that content is complete or suitable for a particular jurisdiction, patient or purpose.

21. IAMRegen intellectual property, brand and database rights

21.1 MSK Regen or its licensors own all rights in the Platform and Association Content, including copyright, database rights, design rights, software rights, trade marks, goodwill, domain names, programme names, logos, crests, badges, templates, taxonomies, assessment frameworks, training materials, recordings, editorial material and the selection and arrangement of databases.

21.2 IAMRegen, I AM Regen, the IAMRegen crest and related names and marks are controlled by MSK Regen. Use of a mark without a registration symbol does not waive any rights.

21.3 Subject to these Terms, we grant an authorised user a limited, personal, non-exclusive, non-transferable, non-sublicensable and revocable licence to access Association Content for the permitted professional, academic or personal purpose of the relevant Service during the period of entitlement.

21.4 Except where law cannot be excluded or a separate licence expressly permits it, you must not:

• copy, republish, sell, sublicense, translate, adapt or create derivative works from Association Content;
• scrape, crawl, harvest, systematically download or reconstruct the Platform or a member database;
• use Association Content or member data to train, test, benchmark or develop an artificial-intelligence or machine-learning system;
• reverse-engineer, decompile or circumvent a technical protection;
• remove rights, authorship, trade mark or provenance notices;
• register or use a confusingly similar company name, domain, social-media handle, keyword, product or service;
• imply endorsement, accreditation, partnership, representation or clinical approval; or
• use Association Content to create a competing directory, membership programme, publication, training product, consensus service or database.

21.5 Rights in open-access publications are governed by the licence displayed with the publication. That licence prevails over section 21.4 for the licensed material only.

21.6 Permitted use of an IAMRegen membership badge, designation or mark is governed by current brand rules, quality-control requirements and the user's status. Permission ends automatically when the relevant entitlement ends and may be suspended to protect the mark or public.

21.7 You must not alter a mark, combine it with another brand, use it as the dominant element of your own identity or suggest that your clinic, product, device or treatment is endorsed unless the written licence expressly allows it.

21.8 We may require evidence of compliant use and may issue reasonable corrective directions. Continued unauthorised use may result in suspension, legal action and recovery of remedies available by law.

22. User Content, licences and feedback

22.1 You retain ownership of User Content, subject to rights held by others and the licences granted in these Terms.

22.2 You confirm that you have all rights, permissions and lawful bases needed to supply User Content and that its use under these Terms will not breach law, confidentiality, privacy, contract, professional duty or intellectual-property rights.

22.3 For ordinary portal and profile content, you grant MSK Regen a worldwide, royalty-free, non-exclusive, transferable and sublicensable licence to host, reproduce, format, secure, moderate, back up, display and communicate the Content to operate, protect and improve the Services. The licence lasts while the Content is used for the Service and for a reasonable backup, legal, audit and dispute period afterwards.

22.4 Where you choose a public profile or public post, the licence includes public display and promotion of the directory or programme. You can change available visibility settings, but removal will not affect lawful prior use, search-engine caches, archived transaction records or formal publications.

22.5 Formal Submissions, consensus contributions, recordings commissioned for IAMRegen and published materials are governed by the broader and, where stated, perpetual licences in sections 17 and 18 or a separate contributor agreement.

22.6 We may create and own service metadata, moderation records, non-personal usage statistics, aggregated analytics and genuinely anonymised datasets generated through operation of the Services. We may use them for administration, safety, research, benchmarking, quality improvement, charitable reporting and development, including computational and artificial-intelligence-assisted analysis, provided personal data and confidentiality obligations are respected.

22.7 Promotional use of a member's testimonial, featured image, identifiable interview or private Content requires an appropriate licence and, where data protection requires, a separate lawful basis or consent.

22.8 If you provide an unsolicited idea, suggestion, correction or feedback about the Services, you grant MSK Regen a perpetual, irrevocable, worldwide, royalty-free, transferable and sublicensable licence to use and exploit it without restriction or payment. To the extent capable of assignment and permitted by law, you assign to MSK Regen intellectual-property rights created specifically as feedback. This does not transfer your pre-existing inventions, clinical methods or research.

22.9 Unsolicited proposals are not confidential merely because they are sent to us. A confidentiality obligation arises only under an existing duty or a written confidentiality agreement signed by an authorised representative of MSK Regen.

22.10 We may remove or restrict User Content reasonably believed to breach these Terms, law, scientific integrity, safety or another person's rights. Content moderation is addressed in section 16.

23. Confidentiality

23.1 Confidential Information includes non-public consensus drafts, peer-review material, unpublished research, embargoed Content, Case MDT material, security information, member-only materials marked or reasonably understood as confidential and information protected by professional duty.

23.2 You must use Confidential Information only for the authorised Service, protect it with reasonable care and disclose it only to a person authorised and bound to protect it.

23.3 Confidentiality does not apply to information that you can show was lawfully public, already lawfully known without restriction, independently developed without use of the information or lawfully received from an unrestricted third party.

23.4 A legally required disclosure may be made if, where lawful and practicable, you give prompt notice and disclose only what is required.

23.5 Confidentiality obligations survive the end of access. Patient confidentiality, trade secrets, peer-review confidentiality and embargoes survive for as long as their nature or applicable law requires.

24. Data protection, privacy and cookies

24.1 MSK Regen processes personal data in accordance with applicable law, including the UK GDPR, Data Protection Act 2018 as amended (including by the Data (Use and Access) Act 2025), Privacy and Electronic Communications Regulations and, where applicable, EU GDPR and local implementing laws.

24.2 The Privacy Notice at Part B explains what we collect, why, lawful bases, sharing, transfers, retention and rights. The Cookie Notice at Part C explains cookies and similar technologies. Each forms part of the transparency information but does not reduce rights under these Terms.

24.3 Users must comply with data-protection and confidentiality law when supplying personal data. A user must not provide another person's data merely because a field permits it.

24.4 Public-profile fields are private by default unless clearly shown otherwise or the user has expressly chosen publication. Marketing choices and sponsor data-sharing choices must be separate and optional.

24.5 We do not sell personal data. We do not provide member contact lists to sponsors or commercial partners for their independent marketing without a valid separate permission or another lawful basis clearly explained in advance.

24.6 If an organisation uses the Services to process personal data for which we act solely as its processor, a compliant data-processing agreement must be in place. The general Case MDT does not authorise identifiable patient data or create such an arrangement.

24.7 We may take urgent steps to secure, quarantine, restrict or delete data that appears unlawful, exposed or outside the permitted purpose, and may make legally required breach or regulatory notifications.

25. Third-party services, links, sponsors and integrations

25.1 Services may use or link to third parties, including payment, authentication, hosting, communications, event, analytics, journal, mapping and video providers. Their own terms and privacy notices may apply to the services they independently provide.

25.2 We select and contract processors using reasonable diligence, but we are not responsible for an independent third-party service outside our control except where law makes us responsible.

25.3 A link, speaker, sponsor, exhibitor, member listing or product mention is not an endorsement. Users should conduct their own assessment.

25.4 A separate agreement may allow a sponsor or partner to deliver a session or benefit. We will identify material commercial relationships and maintain appropriate scientific and editorial controls.

25.5 No sponsor receives identifiable attendee or member information for its independent marketing merely because it sponsored an activity. Any optional lead-sharing or networking consent must be clear and separate.

26. Suspension and termination

26.1 You may close an Account or end membership by contacting us. Ending an Account does not erase records that we must or may lawfully retain, formal publications or surviving licences.

26.2 We may issue a warning, impose conditions, restrict features, suspend or terminate an Account, membership, designation or Service where reasonably necessary because:

• these Terms, a code, law or professional obligation has been breached;
• a Fee is overdue, reversed or fraudulent;
• credentials are false, expired, restricted or cannot reasonably be verified;
• there is a credible risk to a patient, person, event, system, data, scientific record, charity or public;
• Content or conduct is illegal, infringing, unsafe, dishonest or seriously unprofessional;
• a regulator, court, authority, insurer, venue or payment provider requires action; or
• continued provision would expose us or others to disproportionate legal, security or operational risk.

26.3 We may impose an immediate interim restriction without prior notice where delay could cause harm, prejudice an investigation, compromise security or breach law. Interim action is not a final finding.

26.4 Except where inappropriate or unlawful, we will give a concise reason and a reasonable opportunity to respond before a final decision that materially affects paid access or status.

26.5 If we terminate a Consumer's paid Service without fault by the Consumer and without supplying the remaining material benefit, we will provide a proportionate refund or other remedy required by law. No refund is due for a termination caused by the user's serious breach except where mandatory law requires it.

26.6 On termination, access and licences granted to the user end, and use of membership or designation marks must stop. Sections intended by their nature to survive remain effective, including confidentiality, intellectual property, publication licences, payment, liability, indemnity, records and governing law.

27. Reviews, appeals and complaints

27.1 A person affected by a membership, designation, conduct or content-moderation decision may request review within 30 days, stating the decision, grounds and supporting information.

27.2 We may reject an abusive, repetitive, irrelevant or substantially late request, but will consider reasonable explanations for delay.

27.3 A final review will, where practicable, involve a person or panel not solely responsible for the original final decision and without a material conflict. The review may uphold, vary, remit or overturn the decision.

27.4 Reviews do not require disclosure of another person's confidential data, privileged advice, security methods, confidential references or material whose disclosure would cause harm or breach law.

27.5 General service complaints should be sent to [email protected]. We aim to acknowledge within 5 working days and provide a substantive response within 30 days, although complex scientific, safeguarding or cross-border matters may take longer.

27.6 This procedure does not limit a statutory complaint, consumer remedy, regulator report or court right.

27.7 A review does not create a right to remain in a Programme Appointment and does not prevent an interim protective measure. A review of a Programme Appointment may be conducted by the trustees or an Authorised Delegate who was not solely responsible for the original final decision, subject always to the trustees' ultimate authority and the charity's constitution.

28. Changes to these Terms and the Services

28.1 We may update these Terms for changes in law, regulation, Services, technology, security, scientific standards, governance or administrative practice.

28.2 We will identify the version and effective date. For a material change affecting an existing paid period, we will give reasonable advance notice and, where appropriate, require fresh acceptance.

28.3 A material change will not retrospectively remove an accrued statutory right or authorise use of personal data incompatible with the Privacy Notice without a valid lawful basis.

28.4 If a Consumer does not accept a material change that substantially disadvantages the remaining paid Service, the Consumer may stop using the affected Service and request any remedy required by law. Business Users may terminate the affected recurring Service before the change takes effect unless the change is required by law or addresses an urgent safety or security risk.

28.5 Non-material changes, corrections and changes applying only to future purchases may take effect on publication or the stated date.

29. Service availability, security and force majeure

29.1 We use reasonable care to operate and secure the Services but cannot guarantee continuous availability, compatibility with every device or freedom from every defect or cyber incident.

29.2 We may suspend access for maintenance, security, legal compliance, capacity or incident response and will give notice where reasonably practicable.

29.3 Users should retain copies of Content and records they are legally required to keep. The Platform is not a substitute for a clinical record, institutional repository or regulated archival system.

29.4 Neither party is liable for delay or failure caused by events genuinely beyond reasonable control, provided the affected party acts reasonably to mitigate and resume performance. This clause does not allow us to retain a Consumer's payment for a Service that is not supplied where the law requires repayment.

30. Liability where you are a Consumer

30.1 We do not exclude or limit liability where unlawful, including liability for death or personal injury caused by negligence, fraud, fraudulent misrepresentation, breach of statutory title rights or any other non-excludable liability.

30.2 We will provide paid Services with reasonable care and skill. Statutory consumer rights are not restricted.

30.3 Subject to sections 30.1 and 30.2, we are responsible for loss or damage that is a reasonably foreseeable result of our breach of these Terms or failure to use reasonable care and skill. We are not responsible for loss that was not reasonably foreseeable when the contract was made.

30.4 Services are supplied for professional, educational and personal development purposes described in the contract. Where you are a Consumer, we are not responsible for business loss, loss of profit, revenue, opportunity or business interruption.

30.5 We are not responsible for independent clinical decisions, treatment, diagnosis, patient outcomes, professional acts or omissions, use or reliance outside the relevant Service's stated purpose and limits, or an independent third party's acts, except to the extent our own breach legally caused foreseeable loss.

30.6 Nothing in these Terms limits a data subject's rights or compensation available under applicable data-protection law.

31. Liability where you are a Business User

31.1 This section applies only to Business Users. Nothing excludes liability for death or personal injury caused by negligence, fraud, fraudulent misrepresentation or another liability that cannot lawfully be excluded.

31.2 Subject to section 31.1, MSK Regen is not liable for:

• indirect or consequential loss;
• loss of profit, revenue, anticipated saving, business, opportunity, goodwill or reputation;
• loss or corruption of data where the Business User failed to maintain a copy it was reasonably expected to retain;
• clinical decisions, treatment, diagnosis, patient outcomes or professional acts or omissions;
• travel, accommodation, visa or incidental cost, except where expressly agreed; or
• an independent third party's act or service outside our reasonable control.

31.3 Subject to section 31.1, our total aggregate liability arising from a Service in any 12-month period is limited to the greater of:

• the Fees paid or payable by the Business User for the affected Service during that period; and
• GBP 1,000.

31.4 The cap does not apply to an express liability that a separate signed agreement states is subject to a different cap. Each party acknowledges that Fees reflect this allocation of risk.

31.5 Any implied term is excluded only to the extent law permits. No representation binds us unless included in the contract or made by an authorised representative.

31.6 No charity trustee, employee, faculty member, committee member or volunteer has personal contractual liability for an obligation of MSK Regen merely because of their role, without limiting liability for their own non-excludable wrongdoing.

31.7 A Science Board or Case MDT panel member does not become a party to the submitter's contract, assume patient care or incur personal contractual liability merely by participating in a Case MDT. This does not exclude that person's responsibility for their own conduct, advice or wrongdoing where it cannot lawfully be excluded or under their professional regulator's rules.

32. Business User indemnity

32.1 This section applies only to Business Users. The Business User will indemnify MSK Regen against a third-party claim, regulatory cost, damage and reasonable legal expense to the extent directly caused by:

• unlawful or infringing User Content supplied by that Business User;
• unauthorised disclosure or submission of patient or third-party data;
• the Business User's clinical practice, product use or representation made to a patient or customer;
• representing a Case MDT Opinion or Discussion Summary as a treatment authorisation, clinical approval, guarantee, formal second opinion or transfer of responsibility;
• misuse of IAMRegen marks, designation or status;
• fraud, wilful misconduct or material breach of confidentiality; or
• a material breach of these Terms that infringes a third party's rights.

32.2 The indemnity does not cover loss caused by MSK Regen's negligence, breach or unauthorised modification. We will notify the Business User within a reasonable time, permit reasonable participation in the defence and take reasonable steps to mitigate loss. No settlement admitting liability or imposing a non-monetary obligation on the other party may be made without reasonable consent.

33. International use, sanctions and local law

33.1 IAMRegen is operated from England and offered internationally. Users are responsible for laws applying to their professional activities, Content, attendance, import or use of products and access in their location.

33.2 We may restrict a Service, payment, Content, country or person where necessary to comply with sanctions, export controls, anti-money-laundering, anti-bribery, security, tax, professional or other legal requirements.

33.3 A Service's availability in a country does not represent that a treatment, product, designation or activity is lawful or approved there.

33.4 If mandatory consumer, privacy or digital-services law in a user's country grants greater protection, that mandatory protection applies. Nothing in these Terms asks a user to waive a non-waivable right.

33.5 English is the authoritative language of these Terms to the extent permitted by law. A translation may be provided for accessibility. Where mandatory local law requires a local-language term to control, that requirement is preserved.

34. General legal terms

34.1 These Terms and applicable additional terms form the entire agreement about the relevant Service. They do not exclude liability for fraud and do not erase rights arising from mandatory pre-contract information.

34.2 If a provision is unlawful or unenforceable, it will be treated as modified to the minimum extent needed or removed, and the remainder continues.

34.3 Delay in enforcing a right is not a waiver. A waiver must be clear and applies only to the stated circumstances.

34.4 You may not assign or transfer an Account, membership or contract without our written consent. We may transfer a contract to a successor charity or organisation taking over the relevant activities, provided this does not reduce a Consumer's mandatory rights and we give appropriate notice.

34.5 Nothing creates employment, agency, partnership, fiduciary duty or joint venture between a user and MSK Regen.

34.6 Except where expressly stated, a person who is not a party has no right to enforce these Terms under the Contracts (Rights of Third Parties) Act 1999.

34.7 Notices may be given through the portal or to the email associated with the Account. Formal notices to us should be sent to [email protected] and the address in section 1.

34.8 Electronic records, acceptance logs and communications are admissible to the extent permitted by law.

35. Governing law and jurisdiction

35.1 These Terms and any non-contractual dispute are governed by the law of England and Wales.

35.2 If you are a Business User, the courts of England and Wales have exclusive jurisdiction.

35.3 If you are a Consumer, the courts of England and Wales have non-exclusive jurisdiction. You retain any mandatory right to rely on the law or courts of your country of residence.

35.4 Before starting proceedings, the parties should attempt in good faith to resolve the matter through section 27, unless urgent relief, a limitation period or another legal reason makes this inappropriate.